HUTCHMED (China) (HUTCHMED (China)) Total Stockholders Equity : $730.5 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is HUTCHMED (China) Total Stockholders Equity?

HUTCHMED (China)'s Total Stockholders Equity for the quarter that ended in Dec. 2023 was $730.5 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. HUTCHMED (China)'s Book Value per Share for the quarter that ended in Dec. 2023 was $4.28. The ratio of a company's debt over equity can be used to measure how leveraged this company is. HUTCHMED (China)'s Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.12.

HUTCHMED (China) Total Stockholders Equity Historical Data

The historical data trend for HUTCHMED (China)'s Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HUTCHMED (China) Total Stockholders Equity Chart

HUTCHMED (China) Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

288.01

484.12

986.89

610.37

730.54

HUTCHMED (China) Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															986.89	799.73	610.37	782.04	730.54

HUTCHMED (China) (NAS:HCM) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

HUTCHMED (China)'s Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(730.541	-	0)	/	170.729
	=	4.28

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

HUTCHMED (China)'s Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(35.082	+	51.049)	/	730.541
	=	0.12

HUTCHMED (China) Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of HUTCHMED (China)'s Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

HUTCHMED (China) (HUTCHMED (China)) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HUTCHMED (China) Ltd (NAS:HCM) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

00013:Hong Kong HCM.GB:UK HCM:UK H7T2:Germany

Address

2 Queen's Road Central, 48th Floor, Cheung Kong Center, Hong Kong, HKG

Website

https://www.hutch-med.com

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.